| Jessica Lynn Hadwin Phillips, MD | |
|
14795 Sw Murray Scholls Dr Ste 109, Beaverton, OR 97007-9230 | |
| (503) 906-4301 | |
| (503) 906-6613 |
| Full Name | Jessica Lynn Hadwin Phillips |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 3 Years |
| Location | 14795 Sw Murray Scholls Dr Ste 109, Beaverton, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598127144 | NPI | - | NPPES |
| MD208675 | Other | OR | OREGON MEDICAL LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Vincent Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic And Fracture Clinic Pc | 1052219953 | 45 |
News Archive
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.
For women diagnosed with a form of breast cancer known as estrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in the treatment and prevention of recurring breast cancer.
Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care, according to a Penn State College of Medicine study.
MAXIMUS, Inc., a leading provider of government services worldwide, announced today that it has launched its Health Insurance Exchange offerings to help states address the federal regulatory requirements under the Affordable Care Act (ACA).
The science team from Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, met with the Data Safety Monitoring Board (DSMB), an independent group of medical experts, yesterday and received approval to dose all remaining patients in the initial forty (40) patient leg of the 120-patient, cervical dysplasia clinical trial being conducted in the United States.
› Verified 9 days ago
| Entity Name | Orthopedic & Fracture Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285683656 PECOS PAC ID: 1052219953 Enrollment ID: O20040405000622 |
News Archive
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.
For women diagnosed with a form of breast cancer known as estrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in the treatment and prevention of recurring breast cancer.
Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care, according to a Penn State College of Medicine study.
MAXIMUS, Inc., a leading provider of government services worldwide, announced today that it has launched its Health Insurance Exchange offerings to help states address the federal regulatory requirements under the Affordable Care Act (ACA).
The science team from Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, met with the Data Safety Monitoring Board (DSMB), an independent group of medical experts, yesterday and received approval to dose all remaining patients in the initial forty (40) patient leg of the 120-patient, cervical dysplasia clinical trial being conducted in the United States.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Lynn Hadwin Phillips, MD 11782 Sw Barnes Rd Ste 300, Portland, OR 97225-5933 Ph: (503) 214-5200 | Jessica Lynn Hadwin Phillips, MD 14795 Sw Murray Scholls Dr Ste 109, Beaverton, OR 97007-9230 Ph: (503) 906-4301 |
News Archive
CoPlex Therapeutics has signed an exclusive global license agreement with Hawthorn Pharmaceuticals to develop and commercialize hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.
For women diagnosed with a form of breast cancer known as estrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in the treatment and prevention of recurring breast cancer.
Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care, according to a Penn State College of Medicine study.
MAXIMUS, Inc., a leading provider of government services worldwide, announced today that it has launched its Health Insurance Exchange offerings to help states address the federal regulatory requirements under the Affordable Care Act (ACA).
The science team from Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, met with the Data Safety Monitoring Board (DSMB), an independent group of medical experts, yesterday and received approval to dose all remaining patients in the initial forty (40) patient leg of the 120-patient, cervical dysplasia clinical trial being conducted in the United States.
› Verified 9 days ago
Dr. Paul M Puziss, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3800 Sw Cedar Hills Blvd Ste 250, Beaverton, OR 97005 Phone: 503-646-8995 Fax: 503-644-4678 |